Skip to main content

Insider trades

Form 4 filings by directors, officers and 10% owners of US-listed companies, straight from the SEC. Start with a ready-made list, or filter the latest trades below.

Insiders file Form 144 before they sell restricted or control shares: latest Form 144 notices.

Latest trades

Newest filings first. Only open-market purchases (P) and sales (S) by default. The totals above the table follow your filters.

Showing trades filed in the last 7 days, since Nov 10, 2026. Pick dates to see older trades, up to 30 days at a time.

Market-wide lists leave out trades with an obviously wrong reported price and duplicate filings. You can still see them on stock, insider and filing pages.

Trades
1,279
Filings
1,234
Total value
$3.88B
Buys $298.3M, sells $3.58B
Insiders
1,116
Companies
748
Insider trades
CompanyFiled (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
PAYCPaycom Software, Inc.Nov 16, 2026 (view filing)4:10 PM ETNov 133 daysPeck RandallChief Operating OfficerSSale−4.64K$248.84−$1.16M−8.4%50.7K after3 lots
MPBMid Penn Bancorp IncNov 16, 2026 (view filing)4:10 PM ETNov 10-116 daysLateNorcross Philip A10% OwnerPPurchase+19.1K$34.88+$667.2K+0.8%2.56M after2 lots
KROSKeros Therapeutics, Inc.Nov 16, 2026 (view filing)4:10 PM ETNov 124 daysPrener AnneDirectorSSale−574$9.79−$5.62K−4.2%13.2K after10b5-1
LEGNLegend Biotech CorpNov 16, 2026 (view filing)4:10 PM ETNov 12-134 daysSalovey PeterDirectorPPurchase+20.0K$9.16+$183.3K+36.3%75.1K after2 lots
LYNXLyntris Inc.Nov 16, 2026 (view filing)4:10 PM ETNov 124 daysMorrison BrianChief Executive OfficerPPurchase+1.71K$14.55+$24.8K+0.1%1.29M after
DYNDyne Therapeutics, Inc.Nov 16, 2026 (view filing)4:11 PM ETNov 133 daysFriedl-Naderer JohannaChief Commercial OfficerSSale−231$16.82−$3.89K−0.2%152.7K after10b5-1
SEISolaris Energy Infrastructure, Inc.Nov 16, 2026 (view filing)4:11 PM ETNov 124 daysTeague AjDirectorPPurchaseClass A Common Stock+155$64.86+$10.1K+0.1%117.5K after
SEISolaris Energy Infrastructure, Inc.Nov 16, 2026 (view filing)4:11 PM ETNov 13-163 daysTeague AjDirectorPPurchaseClass A Common Stock+400$62.97+$25.2K+2.6%15.5K after2 lots
ELFe.l.f. Beauty, Inc.Nov 16, 2026 (view filing)4:11 PM ETNov 124 daysDaniele Tiffany F.DirectorSSaleCommon Stock, $0.01 par value−900$116.96−$105.3K−10.9%7.36K after
PAMPampa Energy Inc.Nov 16, 2026 (view filing)4:11 PM ETNov 12-134 daysMindlin Damian MiguelVicepresidentPPurchaseAmerican Depositary shares+22.7K$63.29+$1.44M+2.9%792.5K after2 lots
CRVLCorvel CorpNov 16, 2026 (view filing)4:14 PM ETNov 133 daysYoss JenniferVice President of AccountingSSale−2.10K$86.48−$181.6K−48.7%2.21K after
ODFLOld Dominion Freight Line, Inc.Nov 16, 2026 (view filing)4:14 PM ETNov 133 daysStith Thomas A. IIIDirectorSSale−550$173.83−$95.6K−11.4%4.27K after
OBDCBlue Owl Capital CorpNov 16, 2026 (view filing)4:15 PM ETNov 133 daysKaye Eric A.DirectorPPurchase+1.00K$10.81+$10.8K+4.5%23.1K after
OTFBlue Owl Technology Finance Corp.Nov 16, 2026 (view filing)4:15 PM ETNov 133 daysKaye Eric A.DirectorPPurchase+1.00K$9.44+$9.44K+33.3%4.00K after
SENSSenseonics Holdings, Inc.Nov 16, 2026 (view filing)4:15 PM ETNov 133 daysRoeder Douglas ADirectorPPurchase+17.0K$10.32+$175.9K+9.9%189.7K after
ICLRIcon PLCNov 16, 2026 (view filing)4:15 PM ETNov 124 daysMurray CiaranDirectorSSale−10.0K$200.18−$2.00M−58.8%7.00K after
LGNDLigand Pharmaceuticals IncNov 16, 2026 (view filing)4:16 PM ETNov 124 daysZimmermann MartineDirectorSSale−2.00K$318.17−$636.3K−52.9%1.78K after
LFSTLifeStance Health Group, Inc.Nov 16, 2026 (view filing)4:18 PM ETNov 124 daysCoulter James G and 2 others10% OwnerSSale−37.2M$13.02−$484.8M−46.7%42.5M after
MRKMerck & Co., Inc.Nov 16, 2026 (view filing)4:19 PM ETNov 124 daysDeLuca Richard R.EVP&Pres, Merck Animal HeallthSSale−58.2K$148.01−$8.61M−34.0%113.0K after
CVSICV Sciences, Inc.Nov 16, 2026 (view filing)4:19 PM ETNov 4-1112 daysLateCheever Charlie E III10% OwnerPPurchaseCommon+5.44M$0.01+$54.4K+20.4%32.1M after5 lots
EVLVEvolv Technologies Holdings, Inc.Nov 16, 2026 (view filing)4:23 PM ETNov 133 daysCharlton Kevin M.DirectorPPurchaseClass A Common Stock+10.0K$4.00+$40.0K+3.4%301.5K after
LGNDLigand Pharmaceuticals IncNov 16, 2026 (view filing)4:24 PM ETNov 124 daysKozarich John WDirectorSSale−500$325.00−$162.5K−1.2%42.1K after10b5-1
AUPHAurinia Pharmaceuticals Inc.Nov 16, 2026 (view filing)4:25 PM ETNov 133 daysRobertson Stephen P.Chief Legal OfficerSSale−11.9K$15.97−$189.5K−2.0%577.0K after
FTKFlotek Industries IncNov 16, 2026 (view filing)4:26 PM ETNov 133 daysAgadi Harshavardhan VDirectorSSale−15.0K$25.27−$379.0K−7.4%187.4K after
CDNACareDx, Inc.Nov 16, 2026 (view filing)4:26 PM ETNov 124 daysKennedy KeithCFO & COOSSale−2.10K$79.29−$166.3K−1.0%199.1K after2 lots10b5-1
CDNACareDx, Inc.Nov 16, 2026 (view filing)4:27 PM ETNov 124 daysGoldberg MichaelDirectorSSale−13.8K$79.15−$1.09M−22.1%48.5K after3 lots10b5-1
NSPInsperity, Inc.Nov 16, 2026 (view filing)4:28 PM ETNov 133 daysClifford TimDirectorSSale−5.18K$50.19−$259.9K−17.8%23.9K after
AMPLAmplitude, Inc.Nov 16, 2026 (view filing)4:28 PM ETNov 12-134 daysSkates SpenserCEO and PresidentSSaleClass A Common Stock−40$17.47−$698.65−100.0%0 after2 lots10b5-1
GERNGeron CorpNov 16, 2026 (view filing)4:30 PM ETNov 133 daysSemerjian HaroutPresident & CEOPPurchase+53.5K$0.95+$50.8KNew position53.5K after
OSWOnespaworld Holdings LtdNov 16, 2026 (view filing)4:30 PM ETNov 12-134 daysLazarus StephenPresident, CFO and COOSSale−174.6K$30.72−$5.36M−44.6%216.5K after2 lots10b5-1
GERNGeron CorpNov 16, 2026 (view filing)4:30 PM ETNov 16Same dayWilliams TimothyEVP and Chief Legal OfficerPPurchase+12.0K$0.94+$11.3KNew position12.0K after
TCBXThird Coast Bancshares, Inc.Nov 16, 2026 (view filing)4:30 PM ETNov 16Same dayCaraway BartSee RemarksPPurchase+638$39.02+$24.9K+0.4%164.8K after
BIVIBiovie Inc.Nov 16, 2026 (view filing)4:30 PM ETNov 133 daysDo Cuong VPresident & CEOPPurchase+2.50K$1.16+$2.91K+15.5%18.6K after
OMCOmnicom Group Inc.Nov 16, 2026 (view filing)4:30 PM ETNov 124 daysRice Linda JohnsonDirectorSSaleCommon Stock, par value $0.15 per share−697$87.92−$61.3K−5.6%11.8K after
VRTXVertex Pharmaceuticals IncNov 16, 2026 (view filing)4:31 PM ETNov 124 daysWagner Charles F JrEVP, CO & FOSSale−15.3K$547.87−$8.37M−32.5%31.8K after10b5-1
CONConcentra Group Holdings Parent, Inc.Nov 16, 2026 (view filing)4:31 PM ETNov 16Same dayDevasia Thomas A.See RemarksSSale−18.2K$42.93−$781.0K−12.7%125.3K after
PEDPedevco CorpNov 16, 2026 (view filing)4:32 PM ETNov 133 daysKukes Simon G and 1 other10% OwnerPPurchase+8.14K$13.26+$107.9K+0.2%4.15M after
EMREmerson Electric CoNov 16, 2026 (view filing)4:33 PM ETNov 124 daysTrain Michael H.SVP & Chief Sustain OfficerSSale−17.4K$168.54−$2.94M−7.1%227.5K after
PLUSEplus IncNov 16, 2026 (view filing)4:33 PM ETNov 133 daysMarion Elaine DCHIEF FINANCIAL OFFICERSSale−5.00K$96.85−$484.2K−6.3%74.3K after2 lots10b5-1
THMInternational Tower Hill Mines LtdNov 16, 2026 (view filing)4:34 PM ETNov 133 daysWiens David VictorChief Executive OfficerPPurchase+30.0K$1.31+$39.3K+34.6%116.7K after
KINSKingstone Companies, Inc.Nov 16, 2026 (view filing)4:34 PM ETNov 124 daysChen MinleiChief Actuary and Senior VPSSale−8.71K$22.80−$198.6K−20.8%33.2K after2 lots
MOHMolina Healthcare, Inc.Nov 16, 2026 (view filing)4:34 PM ETNov 16Same dayOrlando Steven JDirectorSSale−702$227.33−$159.6K−3.8%17.6K after
UTHRUnited Therapeutics CorpNov 16, 2026 (view filing)4:35 PM ETNov 133 daysRothblatt Martine AChairperson & CEOSSale−9.50K$592.42−$5.63M−2.8%324.4K after12 lots10b5-1
REIRing Energy, Inc.Nov 16, 2026 (view filing)4:35 PM ETNov 133 daysJohl Sundip SinghEVP, Chief Financial OfficerPPurchase+57.9K$1.21+$70.1K+10.6%606.4K after
AMSSAmass BrandsNov 16, 2026 (view filing)4:35 PM ETMay 21-Jun 29179 daysLateLewis Michael V10% OwnerSSale−405.5K$4.86−$1.97M−21.4%1.49M after12 lots
FOURShift4 Payments, Inc.Nov 16, 2026 (view filing)4:35 PM ETNov 16Same dayLauber David TaylorChief Executive OfficerSSaleClass A Common Stock−19.1K$44.38−$845.8K−4.2%431.5K after
TASKTaskUs, Inc.Nov 16, 2026 (view filing)4:36 PM ETNov 124 daysJohnson JarrodChief Customer OfficerSSaleClass A Common Stock−13.5K$8.92−$120.1K−53.6%11.7K after
DGXQuest Diagnostics IncNov 16, 2026 (view filing)4:37 PM ETNov 133 daysDeppe Michael JSVP, Corp. Controller & CAOSSale−11.8K$260.17−$3.06M−25.1%35.2K after2 lots10b5-1
DPUNexpu Ltd.Nov 16, 2026 (view filing)4:38 PM ETNov 124 daysLi YibingDirectorSSaleClass A Ordinary Shares−44.6K$2.10−$93.7K−100.0%0 after
DPUNexpu Ltd.Nov 16, 2026 (view filing)4:38 PM ETNov 124 daysLiao ZhanlinDirectorSSaleClass A Ordinary Shares−37.3K$2.11−$78.7K−83.4%7.40K after